Biology Reference
In-Depth Information
22. To complete the dissociation, allow the mixture to stand for
3 min at room temperature. Then collect 9 ml in another
tube and add 1 ml of HBSSm to the rest and repeat the
dissociation.
23. Cells incubated with biotin-coupled secondary antibody
require further processing with the Vectastain Elite ABC
detection kit.
References
1. Neylan TC (2003) Neurodegenerative disor-
ders: George Huntington's description of
hereditary chorea. J Neuropsychiatry Clin
Neurosci 15:108
2. Stewart JT (1988) Huntington's disease. Am
Fam Physician 37:105-114
3. Charvin D, Roze E, Perrin V, Deyts C,
Betuing S, Pages C, Regulier E, Luthi-Carter
R, Brouillet E, Deglon N, Caboche J (2008)
Haloperidol protects striatal neurons from
dysfunction induced by mutated huntingtin
in vivo. Neurobiol Dis 29:22-29
4. Dorsey R, Biglan K, Eberly S, Auinger P,
Brocht A, Umeh CC, Oakes D, Clarence-
Smith K, Marshall F, Shoulson I, Frank S
(2011) Use of tetrabenazine in Huntington
disease patients on antidepressants or with
advanced disease: results from the
TETRA-HD study. PLoS Curr 3, RRN1283
5. The Huntington's Disease Research
Collaborative Group (1993) A novel gene con-
taining a trinucleotide repeat that is expanded
and unstable on Huntington's disease chromo-
somes. The Huntington's Disease Collaborative
Research Group. Cell 72:971-983
6. Ruocco HH, Lopes-Cendes I, Li LM, Santos-
Silva M, Cendes F (2006) Striatal and
extrastriatal atrophy in Huntington's disease
and its relationship with length of the CAG
repeat. Braz J Med Biol Res 39:1129-1136
7. Rosas HD, Salat DH, Lee SY, Zaleta AK,
Pappu V, Fischl B, Greve D, Hevelone N,
Hersch SM (2008) Cerebral cortex and the
clinical expression of Huntington's disease:
complexity and heterogeneity. Brain 131:
1057-1068
8. Ferrante RJ, Kowall NW, Beal MF, Richardson
EP Jr, Bird ED, Martin JB (1985) Selective
sparing of a class of striatal neurons in
Huntington's disease. Science 230:561-563
9. Li H, Li SH, Johnston H, Shelbourne PF, Li
XJ (2000) Amino-terminal fragments of
mutant huntingtin show selective accumula-
tion in striatal neurons and synaptic toxicity.
Nat Genet 25:385-389
10. Mitchell IJ, Cooper AJ, Griffi ths MR (1999)
The selective vulnerability of striatopallidal
neurons. Prog Neurobiol 59:691-719
11. Han I, You Y, Kordower JH, Brady ST,
Morfi ni GA (2010) Differential vulnerability
of neurons in Huntington's disease: the role
of cell type-specifi c features. J Neurochem
113:1073-1091
12. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH,
Li XJ (2005) Expression of mutant hunting-
tin in glial cells contributes to neuronal exci-
totoxicity. J Cell Biol 171:1001-1012
13. Bradford J, Shin JY, Roberts M, Wang CE, Li
XJ, Li S (2009) Expression of mutant hun-
tingtin in mouse brain astrocytes causes age-
dependent neurological symptoms. Proc Natl
Acad Sci USA 106:22480-22485
14. Bradford J, Shin JY, Roberts M, Wang CE,
Sheng G, Li S, Li XJ (2010) Mutant hunting-
tin in glial cells exacerbates neurological
symptoms of Huntington disease mice. J Biol
Chem 285:10653-10661
15. Faideau M, Kim J, Cormier K, Gilmore R,
Welch M, Auregan G, Dufour N, Guillermier
M, Brouillet E, Hantraye P, Deglon N,
Ferrante RJ, Bonvento G (2010) In vivo
expression of polyglutamine-expanded hun-
tingtin by mouse striatal astrocytes impairs
glutamate transport: a correlation with
Huntington's disease subjects. Hum Mol
Genet 19:3053-3067
16. Varma H (2010) Drug screening for
Huntington's disease and other neurodegen-
erative disorders. Curr Mol Pharmacol 3:
164-173
17. Nakaguchi K, Masuda H, Kaneko N,
Sawamoto K (2011) Strategies for regenerat-
ing striatal neurons in the adult brain by using
endogenous neural stem cells. Neurol Res Int
2011:898012
18. Lundberg C, Bjorklund T, Carlsson T,
Jakobsson J, Hantraye P, Deglon N, Kirik D
(2008) Applications of lentiviral vectors for
biology and gene therapy of neurological dis-
orders. Curr Gene Ther 8:461-473
Search WWH ::
Custom Search